Menu
Menu

🟥 Member Webinar : Hemophilia Alliance Hosts – Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) from BioMarin

All members have the option of attending our various HTC-centric events which include:

« All Events

  • This event has passed.

🟥 Member Webinar : Hemophilia Alliance Hosts – Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) from BioMarin

June 20, 2024 @ 2:00 pm - 3:00 pm

Date: Thursday, June 20, 2024
Time: 2:00pm – 3:00pm ET

BioMarin Logo
Click here to register

Title: Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox)

Objectives:

  • Review coverage and typical prior authorization criteria for ROCTAVIAN
  • Review considerations and pricing education available for single-case agreements
  • Hemophilia Alliance’s gene therapy support for Member Hemophilia Treatment Centers

Speakers:

  • Josh Sammon, PharmD, Senior Director, Market Access, Hemophilia
  • Hemophilia Alliance Team

Details

Date:
June 20, 2024
Time:
2:00 pm - 3:00 pm
Event Categories:
,
Website:
https://attendee.gotowebinar.com/register/8584433075164491358